Both pregnant women carrying fetuses with heart defects and women with hypertensive disorders of pregnancy often exhibit angiogenic imbalances, suggesting that the same mechanisms are involved in the pathogenesis of the former and the pathophysiology of the latter. We conducted a register-based cohort study to determine whether offspring congenital heart defects are associated with an increased risk of hypertensive disorders of pregnancy and whether the mechanisms driving any association are primarily maternal or fetal.
R
ecently, Llurba and colleagues 1 found evidence of angiogenic imbalance in women carrying fetuses with major congenital heart defects and in fetuses terminated because of these defects. The data were consistent with either a fetal or maternal origin for the angiogenic imbalance.
1,2 A fetal imbalance toward antiangiogenesis at the trophoblast stage could result in abnormal heart formation, with subsequent transplacental fetal distress signals triggering a maternal response. Alternatively, a maternal antiangiogenic state might reduce trophoblast invasion of the spiral arteries, leading to placental hypoxia, fetal hypoxia, fetal overproduction of antiangiogenic factors, and abnormal heart development. Either way, the data suggested that excessive antiangiogenesis early in pregnancy may play a role in the origin of at least some congenital heart defects.
Preeclampsia is also characterized by an angiogenic imbalance toward antiangiogenesis that becomes more marked with increasing disease severity and earlier gestational age at onset. [3] [4] [5] [6] [7] [8] [9] [10] [11] An association between maternal hypertensive disorders of pregnancy and offspring congenital heart defects is therefore biologically plausible and would suggest that the same underlying processes contribute to the pathophysiology of both conditions. The association is challenging to study, however, because both heart defects and the more severe and early-onset forms of preeclampsia (those forms for which there is the strongest evidence of angiogenic imbalance) are relatively rare. Nevertheless, a Norwegian register-based study recently found associations between preeclampsia, early-onset (<34 weeks' gestation) preeclampsia in particular, and severe congenital heart defects. 12 Published almost simultaneously, a Canadian study based on hospital discharge records found strong associations between early-onset preeclampsia and both critical and noncritical congenital heart defects; later-onset preeclampsia was only modestly associated, if at all, with congenital heart defects. 13 Using information from Denmark's national registers, we conducted a population-based cohort study to identify specific offspring heart defect subtypes associated with maternal hypertensive disorders of pregnancy and to pinpoint whether maternal or fetal mechanisms contribute most to the observed associations. To investigate associations with specific heart defect subtypes, we examined the association between carrying a fetus with a congenital heart defect and maternal risk of hypertensive disorders of pregnancy later in the same pregnancy. To assess the relative contribution of maternal and fetal mechanisms, we investigated associations between offspring congenital heart defects and maternal hypertensive disorders of pregnancy in different pregnancies in the same woman. Here, we investigated whether hypertensive disorders of pregnancy in one pregnancy were associated with the risk of offspring congenital heart defects in later pregnancies and whether congenital heart defects in the offspring of one pregnancy were associated with the risk of hypertensive disorders of pregnancy in later pregnancies.
METHODS

Study Cohorts
Analyses of Events Occurring in a Single Pregnancy
Using the Medical Birth Register, we constructed a study cohort that included singleton pregnancies in Denmark lasting ≥20 completed weeks and ending in live birth in 1978 to 2011. The 20-week entry criterion was chosen because by definition women are at risk of hypertensive disorders of pregnancy after 20 weeks' gestation (ie, most clinicians will not assign such a diagnosis until after 20 weeks' gestation) and because most pregnancy terminations will have occurred by 20 weeks. Because Denmark's national registers do not routinely record congenital abnormalities in stillbirths, our primary analyses focused only on pregnancies ending in live birth. We excluded multiple gestations (using information from the Hospital Discharge Register and the Medical Birth Register) because multiple gestation increases the risks of both congenital heart defects and hypertensive disorders of pregnancy. Last, we used information from the Hospital Discharge Register and the
Clinical Perspective
What Is New?
• Offspring congenital heart defects were strongly associated with maternal preterm preeclampsia, early preterm preeclampsia (preeclampsia necessitating delivery <34 weeks) in particular.
• The associations were observed across heart defect subtypes.
• The associations were observed both in the same pregnancy and across pregnancies in the same woman, implicating maternal processes in the associations.
What Are the Clinical Implications?
• The same pathophysiological mechanisms may be involved in a proportion of both congenital heart defects and preterm preeclampsia.
• Clarification of preeclampsia mechanisms may therefore contribute to understanding how heart defects arise during embryogenesis.
• A maternal history of preeclampsia, preterm preeclampsia in particular, might justify increased surveillance for congenital heart defects not only in the offspring of pregnancies complicated by preeclampsia but also in the offspring of the woman's uncomplicated pregnancies.
• The presence of congenital heart defects in a fetus would seem to justify increased clinical monitoring for preeclampsia in both the affected pregnancy and subsequent pregnancies.
Danish Cytogenetic Central Register to exclude pregnancies ending in the birth of a child with chromosomal abnormalities because we were interested only in nonchromosomal congenital heart defects. (See the online-only Data Supplement for information on the registers used as data sources.)
Analyses of Events Occurring Across Multiple Pregnancies
The study cohort included women with ≥2 live singleton births in Denmark in the period from 1978 to 2011. In these analyses, we once again ignored stillbirths because of data limitations.
Sensitivity Analyses
The study cohort for these analyses consisted of singleton pregnancies fulfilling all the criteria listed for the single-pregnancy analyses, with the addition of those ending in singleton stillbirth (identified using the Medical Birth Register).
Data and Ethics Approvals
The study was registered with the Danish Data Protection Agency and approved by the Board of the Danish Cytogenetic Central Register. In Denmark, studies based solely on register data do not require further ethics committee approval.
Ascertainment of Congenital Heart Defects
Among the offspring of women contributing pregnancies to the study cohorts, we identified individuals with congenital heart defects using the Hospital Discharge Register. We considered individuals registered with any of the following International Classification of Disease (ICD) codes, regardless of age at diagnosis, to have congenital heart defects: ICD-8 codes 746.00 to 747.49, 759.00, 759.01, and 759.09, and ICD-10 codes Q20.0 to Q26.9 and Q89.3. Congenital heart defects were then classified with the use of an hierarchical algorithm developed by Leirgul and colleagues 14 ( Table I in the online-only Data Supplement).
Ascertainment of Hypertensive Disorders of Pregnancy
A woman was considered to have a hypertensive disorder of pregnancy in a given pregnancy if she was registered in the Hospital Discharge Register with such a disorder (preeclampsia or gestational hypertension) between 30 days before delivery and 7 days postpartum. (To be conservative in our identification of affected pregnancies, women whose only diagnoses were registered >30 days before delivery or >7 days postpartum were not considered to have had a hypertensive disorder of pregnancy.) Preeclampsia/ eclampsia was registered with ICD-8 codes 637.03, 637.04, 637.09, 637. 19, 637.99, 762.19, 762 .29, and 762.39, and ICD-10 codes O14.0 to O15.9. We defined early preterm preeclampsia as preeclampsia with delivery at <34 weeks' gestation, late preterm preeclampsia as preeclampsia with delivery at 34 to 36 weeks, and term preeclampsia as preeclampsia with delivery at ≥37 weeks. Gestational hypertension was defined as registration of ICD-8 code 637.00 or ICD-10 codes O13.9 or O16.9, 15, 16 with no registration of preeclampsia at any point during pregnancy and delivery at any gestational age.
Statistical Analysis
Analyses of Events Occurring in a Single Pregnancy
Using polytomous logistic regression, we estimated odds ratios (ORs) for the association between carrying a fetus with a congenital heart defect and the odds (interpreted as risk because neither congenital heart defects nor hypertensive disorders of pregnancy, preeclampsia in particular, are common) of early preterm preeclampsia, late preterm preeclampsia, term preeclampsia, and gestational hypertension later in the pregnancy (Figure 1 ). All estimates were adjusted for maternal age at delivery (<20, 20-24, 25-29, 30-34, and ≥35 years, from the Civil Registration System), parity (0, 1, ≥2, from the Medical Birth Register), and delivery year (1-year intervals, from the Civil Registration System). We also investigated the impact of adjusting for pregestational maternal ischemic disease (ICD-8 codes 410.09-414.99, ICD-10 codes I20.0-I25.9, registered in the Hospital Discharge Register) and offspring sex (from the Civil Registration System). We then examined associations between hypertensive disorders of pregnancy and individual congenital heart defect phenotypes.
Our main analyses included all eligible pregnancies in the study period. However, we also conducted analyses restricted to a woman's first eligible pregnancy in the study period to check that any within-woman correlation of outcomes 17 did not affect our results.
Analyses of Events Occurring Across Multiple Pregnancies
We estimated ORs for the associations between a hypertensive disorder of pregnancy in a previous pregnancy and the risk of offspring congenital heart defects in a later pregnancy (the current pregnancy, ie, the pregnancy in which the outcome was being ascertained; scenario 1) and between offspring congenital heart defects in a previous pregnancy and the risk of hypertensive disorders of pregnancy in the current pregnancy (scenario 2; Figure 1 and Figure I in the online-only Data Supplement). The analyses in scenario 1 were conducted with logistic regression; scenario 2 analyses used polytomous logistic regression. All analyses were adjusted for maternal age, parity, and delivery year in the current pregnancy. When offspring congenital heart defects in the current pregnancy were the outcome of interest (scenario 1), we also adjusted for maternal hypertensive disorders of pregnancy in the current pregnancy, as well as the presence or absence of maternal congenital heart defects (information from the Hospital Discharge Register). When maternal hypertensive disorders of pregnancy in the current pregnancy were the outcome of interest (scenario 2), we also adjusted for offspring congenital heart defects in the current pregnancy.
Both within-and between-pregnancy analyses were conducted with the SAS procedure LOGISTIC (SAS version 9.4, SAS Institute, Inc, Cary, NC). All statistical tests were Wald tests.
Sensitivity Analyses
Because a portion of stillbirths likely had congenital heart defects, we conducted a sensitivity analysis of the impact of including pregnancies ending in stillbirth in the analyses of events within a single pregnancy (see the online-only Data Supplement for a description of the statistical methods used). To investigate the degree to which any observed association with maternal hypertensive disorders of pregnancy was specific to offspring congenital heart defects (which would support angiogenic imbalance as a potential mechanistic link), we also estimated ORs for the association between major offspring noncardiac defects and maternal hypertensive disorders in the same pregnancy.
RESULTS
Single-Pregnancy Analyses
The cohort included 1 972 857 singleton pregnancies without offspring chromosomal abnormalities lasting ≥20 weeks. Of these, 18 038 (0.9%) involved a congenital heart defect in the offspring. Early preterm and late preterm preeclampsia complicated 3617 (0.2%) and 5512 (0.3%) pregnancies, respectively. Term preeclampsia was registered for 45 611 (2.3%) pregnancies, and gestational hypertension alone was registered in 17 975 (0.9%) pregnancies.
Women carrying a fetus with a congenital heart defect had a 7-fold increased risk of early preterm preeclampsia and an almost 3-fold increased risk of late preterm preeclampsia in the same pregnancy compared with women whose fetus had no congenital heart defect (Table 1) . In contrast, an offspring congenital heart defect was associated with only a 16% increase in term preeclampsia risk and was not associated with gestational hypertension risk ( Table 1 ). The effect magnitudes were similar for nulliparous and parous women and for women <30 and ≥30 years of age at the time of delivery (Table II in the online-only Data Supplement). Neither restriction to a woman's first eligible registered pregnancy nor additional adjustment for pregestational maternal ischemic heart disease or offspring sex changed the results appreciably (Table II in Most offspring congenital heart defect phenotypes were strongly and significantly associated with increased maternal risk of early preterm preeclampsia (8 of 13 phenotypes; 5 ORs between 6.80 and 12.0) and/or late preterm preeclampsia (8 of 13 phenotypes; OR range, 1.93-6.82) in the same pregnancy ( Table 1) . Many of the remaining phenotype-specific analyses lacked power because of a dearth of pregnancies complicated by both the congenital heart defect of interest and preterm preeclampsia. A more limited group of congenital heart defect phenotypes also appeared to be associated, albeit more modestly, with maternal risk of term preeclampsia, while there was no evidence that specific congenital heart defects were associated with gestational hypertension risk ( Table 1 ). 
Cross-Pregnancy Analyses
The cohort included 705 678 women with ≥2 pregnancies ending in the live birth of singletons without chromosomal abnormalities during the follow-up period. Preterm preeclampsia in a previous pregnancy was associated with an increased risk of offspring congenital heart defects in the current pregnancy, with early preterm preeclampsia associated with an almost 8-fold increase in offspring congenital heart defect risk and late preterm preeclampsia associated with an almost 3-fold increase in risk (Table 2) . Neither term preeclampsia nor gestational hypertension in a previous pregnancy was associated with congenital heart defects in the offspring of the current pregnancy (Table 2) . Adjustment for the presence of maternal congenital heart defects did not affect estimate magnitudes ( Table 2 footnote). Although additional adjustment for a hypertensive disorder of pregnancy in the current pregnancy somewhat reduced the estimates for preterm preeclampsia, the strong cross-pregnancy associations persisted: The OR for offspring congenital heart disease in the current pregnancy was 6.45 (95% confidence interval [CI], 4.91-8.49) for early preterm preeclampsia in a previous pregnancy and 2.41 (95% CI, 1.79-3.25) for late preterm preeclampsia (Table 2 footnote). Although all congenital heart defect phenotypes were represented among current pregnancy offspring, we had insufficient power to estimate ORs for individual phenotypes.
Women who previously had had a child with a congenital heart defect had 2-fold greater risks of both Odds ratios were adjusted for maternal age, parity, and delivery year. CI indicates confidence interval; and OR, odds ratio. *Early preterm preeclampsia: preeclampsia necessitating delivery at <34 weeks; late preterm preeclampsia: preeclampsia necessitating delivery at 34 to 36 weeks; term preeclampsia: preeclampsia with the baby delivered at ≥37 weeks; and gestational hypertension: delivery at any gestational age.
†See Table I in the online-only Data Supplement for phenotype definitions.
early preterm and late preterm preeclampsia and a 25% greater risk of term preeclampsia in the current pregnancy compared with women whose previous offspring did not have congenital heart defects ( Table 3) . In contrast, congenital heart defects in the offspring of a previous pregnancy were not associated with gestational hypertension risk in the current pregnancy (Table  3) . Adjustment for offspring congenital heart defects in the current pregnancy slightly reduced the magnitudes of the estimates for early and late preterm preeclampsia (by 13% and 4%, respectively) but did not affect the estimates for term preeclampsia and gestational hypertension (Table 3 footnote). Our statistical power to look at associations with specific congenital heart defects phenotypes in the offspring of a previous pregnancy was limited to 5 phenotypes and required that we combine early and late preterm preeclampsia. Consistent with the results of the single-pregnancy analyses, preterm preeclampsia risk in the current pregnancy was associated, often strongly, with diverse congenital heart defect phenotypes in the offspring of a previous pregnancy (Table 4 ). Figure 2 summarizes ORs for the association between offspring congenital heart defects and hypertensive disorders of pregnancy in a single pregnancy and across pregnancies separately for early preterm preeclampsia, late preterm preeclampsia, term preeclampsia, and gestational hypertension.
Sensitivity Analyses
During the study period, 8627 singleton pregnancies ended in stillbirth with known gestational age. Of these pregnancies, 184 (2.1%) were affected by early preterm preeclampsia, 79 (0.9%) by late preterm preeclampsia, 120 (1.4%) by term preeclampsia, and 108 (1.3%) by gestational hypertension (Table III in the online-only Data Supplement). Assuming that 1.8% of the stillbirths had a congenital heart defect, as suggested by a Norwegian population-based study, 14 we estimat- Odds ratios were adjusted for maternal age, parity and offspring birth year. CI indicates confidence interval; and OR, odds ratio. *Early preterm preeclampsia: preeclampsia necessitating delivery at <34 weeks; late preterm preeclampsia: preeclampsia necessitating delivery at 34 to 36 weeks; term preeclampsia: preeclampsia with the baby delivered at ≥37 weeks; and gestational hypertension: delivery at any gestational age.
Additional adjustment for fetal heart defects in the current pregnancy yielded the following estimates: early preterm preeclampsia: OR, 2.06; 95% CI, *Early preterm preeclampsia: preeclampsia necessitating delivery at <34 weeks; late preterm preeclampsia: preeclampsia necessitating delivery at 34 to 36 weeks; term preeclampsia: preeclampsia with the baby delivered at ≥37 weeks; and gestational hypertension: delivery at any gestational age.
ed unadjusted ORs of 7.59, 2.91, 1.15, and 1.05 for early preterm preeclampsia, late preterm preeclampsia, term preeclampsia, and gestational hypertension, respectively, when we included stillbirths in our analyses of events within a single pregnancy. The corresponding ORs estimated when only live births were included in the analyses were 7.30, 2.88, 1.15, and 1.05. If we assumed that a larger proportion (5%) of stillbirths had a congenital heart defect, the unadjusted ORs were 8.41, 2.99, 1.14, and 1.06. Table 5 shows associations between major offspring noncardiac defects and maternal hypertensive disorders of pregnancy in the same pregnancy. Compared with women carrying a fetus without congenital defects, women carrying a fetus with a noncardiac defect had twice the risk of early preterm preeclampsia, a 60% increase in risk of late preterm preeclampsia, a very modest (9%) increase in term preeclampsia risk, and no increase in risk of gestational hypertension (Table 5) .
DISCUSSION
In a cohort of almost 2 million pregnancies, offspring congenital heart defects were associated with a 7-fold increase in the risk of early preterm preeclampsia in the same pregnancy, an almost 3-fold increase in late preterm preeclampsia risk, and a 16% increase in term preeclampsia risk compared with carrying a child with no heart defect. In contrast, offspring congenital heart defects were not associated with gestational hypertension risk in the same pregnancy. The strong associations with preterm preeclampsia were consistent across individual heart defect phenotypes. We also found that preterm preeclampsia, early preterm preeclampsia in particular, and offspring congenital heart defects were associated across pregnancies. Early preterm preeclampsia in a previous pregnancy was associated with an almost 8-fold increased risk of offspring congenital heart defects in the current pregnancy, and late preterm preeclampsia in a previous pregnancy was associated with an almost 3-fold increase in risk. Congenital heart defects in the offspring of a previous pregnancy were associated with doubling of the risk of both early and late preterm preeclampsia in the current pregnancy.
The observed associations suggest that the same pathophysiological mechanisms are involved in the Odds ratios for the association between offspring congenital heart defects and early preterm preeclampsia (early PT-PE), late preterm preeclampsia (late PT-PE), term preeclampsia (term PE), and gestational hypertension (GH) in the same pregnancy (red diamonds) and different pregnancies (green squares, association between hypertensive disorders of pregnancy in a previous pregnancy and offspring congenital heart defects in the current pregnancy; blue circles, association between a history of offspring congenital heart defects and hypertensive disorders of pregnancy in the current pregnancy). Odds ratios were adjusted for maternal age, parity, and offspring birth year. CI indicates confidence interval; and OR, odds ratio. *Early preterm preeclampsia: preeclampsia necessitating delivery at <34 weeks; late preterm preeclampsia: preeclampsia necessitating delivery at 34 to 36 weeks; term preeclampsia: preeclampsia with the baby delivered at ≥37 weeks; and gestational hypertension: delivery at any gestational age.
†For women with multiple offspring with heart defects, we considered the offspring heart defect phenotype in the child born most recently.
pathogenesis of a certain proportion of both congenital heart defects and preterm preeclampsia, early preterm preeclampsia in particular. Identification of these shared mechanisms might improve our ability to identify women at risk for these adverse events and possibly even suggest targets for preventive treatment. Possible candidate mechanisms include endothelial dysfunction, angiogenic imbalance, smooth muscle abnormalities, dyslipidemia, and subclinical metabolic disorders.
Whether an angiogenic imbalance and abnormal angiogenesis themselves play a direct role, as suggested by Llurba and colleagues, 1 rather than simply serving as markers of another pathological process, cannot be determined from this study. However, the strong associations observed for early preterm preeclampsia support the involvement of some form of endothelial dysfunction because poor implantation, placental insufficiency, and endothelial dysfunction are thought to be central to the pathogenesis of early-onset preeclampsia, whereas other mechanisms are probably involved in the pathogenesis of late-onset preeclampsia and gestational hypertension. [18] [19] [20] Our cross-pregnancy results support a predominantly maternal origin of effect rather than an effect originating in altered fetal angiogenesis. If abnormal fetal angiogenic processes were to blame for offspring congenital heart defects and for the association between those defects and maternal preeclampsia, one would not expect to see associations between offspring congenital heart defects in one pregnancy and maternal preeclampsia in another pregnancy, particularly after adjustment for recurrence of heart defects in the offspring and hypertensive disorders of pregnancy in the mother. The cross-pregnancy results may also challenge the conventional obstetric assumption that abnormal placentation is always central to the development of angiogenic imbalance and preterm preeclampsia because abnormal placentation in one pregnancy is unlikely to be associated with congenital heart defects in the offspring of another pregnancy. Our results suggest that other maternal factors may also play an important role in preterm preeclampsia, as has recently been hypothesized. 21, 22 Llurba and colleagues 1 found evidence of angiogenic imbalances in women carrying fetuses with conotruncal and valve defects but not in women whose fetuses had left heart defects. In a case-control study of maternal hypertensive disorders of pregnancy and selected major birth defects, preeclampsia superimposed on untreated chronic hypertension was strongly associated with both atrial and ventricular septal defects, whereas de novo preeclampsia was associated with atrial septal defects and possibly left-sided defects and aortic arch anomalies. 23 In contrast, we observed strong associations between most heart defect phenotypes and preterm preeclampsia, both within and between pregnancies. Our much larger sample size may simply have allowed us to capture associations that the previous studies had limited power to detect. In a recent large study, Auger and colleagues 13 found that early-onset preeclampsia (debut <34 weeks) was associated with a 2.8-fold increase in the prevalence of critical congenital heart defects in the offspring and a 5.6-fold increase in the prevalence of noncritical heart defects, somewhat weaker associations than those observed in our study; late-onset preeclampsia (debut ≥34 weeks) was associated with only a modest increase in the prevalence of offspring noncritical heart defects. Brodwall and colleagues 12 found an association of similar size between early-onset preeclampsia and severe offspring congenital heart defects; however, they also found that late-onset preeclampsia was associated with a 1.7-fold increase in risk of severe heart defects. Differences be- tween these 2 studies and ours in the range of individual heart defects for which associations were observed and strengths of association may reflect differences in study design, preeclampsia definition, congenital heart defect phenotyping, or study power.
The nonselective nature of the observed associations with regard to specific congenital heart defect subtype suggests that the processes underlying these associations do not influence only specific sequences in cardiac development; if they did, we would expect to see associations with specific heart defects corresponding to errors in fetal heart development at specific times during heart development. Instead, the underlying processes may either affect cardiac development in general or exert their harmful effects very early in pregnancy, possibly at the time of primitive heart tube formation.
Although we also observed associations between noncardiac defects and both early and late preterm preeclampsia, these associations were not as strong as those observed for congenital heart defects. Noncardiac defects were associated with less than a third of the increase in early preterm preeclampsia risk and roughly half the increase in late preterm preeclampsia risk observed for congenital heart defects. These findings suggest that although offspring birth defects may be a general modest risk factor for preterm preeclampsia, heart defects and preterm preeclampsia likely share specific mechanistic underpinnings.
The reliability of register-based studies depends particularly on the specificity of registered diagnoses. Validation of congenital heart defect diagnoses in the Hospital Discharge Register against hospital records revealed that virtually all patients classified as having congenital heart defects do in fact have a heart defect, and in 90% of cases, the registered diagnosis accurately reflects the patient's specific defect. 24 Validation of codes for hypertensive disorders of pregnancy against American College of Obstetrics and Gynecology definitions (2002) 25 showed that the register's specificity for hypertensive disorders of pregnancy exceeded 99%. 26 Therefore, although registration of congenital heart defects and hypertensive disorders of pregnancy may be incomplete (particularly for milder heart defects and gestational hypertension), those diagnoses that are recorded are likely correctly registered. Because of this high specificity and because congenital heart defects and hypertensive disorders of pregnancy (preterm preeclampsia, in particular) occur relatively infrequently, any bias due to misclassification of hypertensive pregnancies as normotensive or of offspring with heart defects as unaffected is most likely negligible.
Because women receive a diagnosis of preeclampsia or gestational hypertension only after gestational week 20, we required that pregnancies last ≥20 weeks to be included in the study. Pregnancies ending in early termination, a small proportion of which certainly involved fetuses with congenital heart defects, were therefore excluded from our study. However, because the decision to terminate did not take the probability of later hypertensive disorders of pregnancy into consideration, disregarding these pregnancies was unlikely to have induced selection bias. Pregnancies terminated after week 20 were not included in our main analyses because we had no information on heart defects in aborted fetuses. However, relative to the number of live births or even to the number of stillbirths, very few pregnancies eligible for inclusion will have ended in termination, and even fewer will have been terminated because of congenital heart defects.
We had no information on congenital heart defects in stillbirths. However, when we included stillbirths in our cohort and modeled heart defect status on the basis of published heart defect prevalences in stillbirths, our estimates were virtually unchanged, suggesting that excluding stillbirths from our primary analyses biased our results little, if at all.
We considered maternal pregestational heart disease, maternal and fetal congenital heart defects, and maternal obesity to be the most important potential confounders of the observed associations. Adjustment for congenital heart defects and maternal heart disease did not affect our results. We could not adjust for obesity because prepregnancy body mass index has been registered only since 2004; however, maternal obesity is predominantly associated with term preeclampsia, and we observed the strongest associations for preterm preeclampsia. Smoking may be modestly associated with offspring heart defect risk 27 but is associated with a reduced risk of hypertensive disorders of pregnancy 28 such that any confounding by smoking would have caused us to underestimate association magnitudes.
CONCLUSIONS
We observed strong associations between congenital heart defects and risk of preterm preeclampsia both in the same pregnancy and across pregnancies. Our findings support a predominantly maternal origin of effect, although they do not rule out an additional fetal contribution. Clarification of the mechanisms underlying preterm preeclampsia may help to identify how congenital heart defects arise during embryogenesis.
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